The encouraging news would mean more people could be set to receive their second doses as Britain ramps up vaccinations. It would also mean over 50s could be invited to take the vaccine later this month, according to Mail Online.
Last week, Health Secretary Matt Hancock announced that the Oxford University vaccine is more efficient than the Pfizer jab.
The first real-world figured of the UK’s immunisation scheme showed the first dose of Oxford vaccine has a bigger effect on reducing infection than its Pfizer counterpart.
Also, a single dose of either jab slashes hospitalisation by over 80 percent.
Last Monday, Mr Hancock described the data as “exciting” and “extremely good news”.
He added: “In fact, the detailed data show that the protection that you get from catching COVID 35 days after a first jab is even slightly better for the Oxford jab than for Pfizer, albeit both results are clearly very strong.”
A Public Health England (PHE) report on vaccine effectiveness stated: “Protection against symptomatic COVID, four weeks after the first dose, ranged between 57 and 61 percent for one dose of Pfizer and between 60 and 73 percent for the Oxford-AstraZeneca vaccine.”
Dr Mary Ramsay, PHE Head of Immunisation, labelled the report as “encouraging” but urged the public to continue to abide by the public health measures even after receiving the jab.
She said: “This adds to growing evidence showing that the vaccines are working to reduce infections and save lives.